Finzati - Logo
SMLR logo

Semler Scientific, Inc.

SMLR • Medical - Devices
$20.33
▼ -1.04 (-4.87%)
Current price
EarningsLatest report: Sep 30, 2025
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$336.36M
Growth
38.5%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Stable or improving margins · 72.7%Positive revenue growth · 7.4%Consistent free cash flow · 4/5Reasonable earnings multiple · 9.54Manageable debt level · 0
Financial data as of: Sep 30, 2025, 12:00 AM UTCLast earnings update: Nov 12, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$20.33
Change-4.87%
Shares Out16.55M
Market Cap$336.36M
Enterprise Value$442.61M
52W Range14.88 - 65.98
Beta1.32
P/E6.96
P/S9.10
P/B0.73
P/FCF-4.42
EV/Sales11.98

Investment DNA

How strong this company looks for long-term investors

76
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
76/100
Price Attractiveness
Cheap or expensive today
71/100
Why this score▼
Stable or improving margins · 72.7%Positive revenue growth · 7.4%Consistent free cash flow · 4/5Reasonable earnings multiple · 9.54Manageable debt level · 0Healthy liquidity · 3.59

Analyst view

Analyst sentiment and price target

SMLR
Analyst sentiment
Based on 7 analyst votes · 2026-09-05
93/100
Bullish
Bullish
6
Hold
1
Bearish
0
Price Target
2026-06-06
Low
$40.00
Mean
$50.50
Median
$50.50
High
$61.00

Company Overview

IPO: 2/21/2014
Industry: Medical - Devices
P/B i: 0.73
Debt / Equity i: 0.00
Operating Margin: 37.19%
Net Margin: 72.65%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.00
Current Ratio: 3.59
Quick Ratio: 3.54
Status: Good

Insider Transactions

Recent executive and insider activity

⚠ 3 high-volume insider sells detected
Chang William H
Transaction: 01/16/2026
SELL
Change
-241,508
Price
Not reported
Filing
01/16/2026
Type
SELL
Chang William H
Transaction: 01/16/2026
BUY
Change
+1,000
Price
$58.94
Filing
01/16/2026
Type
BUY
BRUNELL NATALIE
Transaction: 01/16/2026
BUY
Change
+1,875
Price
$31.79
Filing
01/16/2026
Type
BUY